Delamain, Marcia Torresan https://orcid.org/0000-0001-9071-4397
Cardoso, Ana Carolina Ferreira https://orcid.org/0000-0002-9612-2285
Pericole, Fernando Vieira https://orcid.org/0000-0003-2369-0545
da Silva Araújo, Sérgio Shusterschitz https://orcid.org/0000-0002-3944-7235
Fogliatto, Laura https://orcid.org/0000-0002-0610-7971
Higashi, Marcia https://orcid.org/0000-0003-2475-9954
Pereira, Juliana https://orcid.org/0000-0002-0655-2821
da Silva, Roberto Luiz https://orcid.org/0000-0001-5445-7194
Werutsky, Gustavo https://orcid.org/0000-0001-6271-105X
de Paulo Giacon Radtke, Patrícia https://orcid.org/0009-0005-5733-2705
Salvino, Marco Aurélio https://orcid.org/0000-0001-5885-869X
Castilho, Vivienne https://orcid.org/0000-0003-0784-6642
Funding for this research was provided by:
Libbs Farmaceutica
Article History
Received: 25 December 2023
Accepted: 14 May 2024
First Online: 3 June 2024
Declarations
:
: Financial interests: Marcia Torresan Delamain, Fernando Pericole, Sérgio Shusterschitz da Silva Araújo, Laura Maria Fogliatto, Juliana Pereira, Roberto Luiz da Silva, Patrícia de Paulo Giacon Radtke and Marco Aurélio Salvino declare they do not have financial interests. Gustavo Werutsky received consultant honoraria from Libbs Farmaceutica. Marcia Higashi received honoraria for presentations from Pfizer, AstraZeneca, and Janssen and honoraria for participation in scientific meetings from Roche, Pfizer, and Janssen. Ana Carolina Ferreira Cardoso and Vivienne Castilho are currently employed at Libbs Farmacêutica.
: This study was performed following the Helsinki Declaration of 1964 and its subsequent amendments, and was approved by the Research Ethics Committee (CEP) of Centro de Hematologia e Hemoterapia—HEMOCENTRO, number 4.737.891 (CAAE: 46,518,321.2.1001.5404). All participants provided the signed informed consent form before participating in the study. The participants remained anonymous and were granted the right to step out of the study at any time during the research period.